Pharmaceuticals

Johnson & Johnson resumes merger talks with Actelion Pharmaceuticals

26 Dec 2016

US antitrust regulators close to approving Abbott-St. Jude Medical deal

24 Dec 2016

Antibiotic sales for farm use increased 1 per cent in 2015

23 Dec 2016

Teva Pharmaceutical to pay $519 mn to settle US bribery charges

23 Dec 2016

US Senate for curbs on "price gouging" of life saving drugs

22 Dec 2016

Actelion in exclusive negotiations with J&J after talks with Sanofi

22 Dec 2016

Sun Pharma acquires Novartis' oncology brand Odomzo

22 Dec 2016

Allergan to buy regenerative medicine specialist LifeCell for $2.9 bn

21 Dec 2016

Sweden’s SCA to buy German bandage and plaster cast maker BSN Medical for $2.9 bn

20 Dec 2016

Sun asks US FDA to withdraw nod for 28 Ranbaxy ANDAs

20 Dec 2016

After Pfizer, Actavis accused of hiking drug price by 12,000%

17 Dec 2016

A week after Pfizer was slapped with a record fine of £84.2 million for unfair price hikes, the UK’s Competition and Markets Authority has accused Actavis of hiking the price of a drug from 70p to £88 a pack

Teva Pharmaceuticals and Mylan accused of brazen price fixing

16 Dec 2016

Novartis to buy privately-held British biotech company Ziarco Group

16 Dec 2016

Merck wins $2.54 bn in royalties in patent lawsuit

16 Dec 2016

J&J being sued over Risperidal causing breasts in men

16 Dec 2016

Lonza to buy US capsule products manufacturer Capsugel for $5.5 bn

16 Dec 2016

Cipla to set up manufacturing facility in Iran in JV with Ahran Tejarat

15 Dec 2016

Spain’s Grifols SA to buy Hologic's stake in blood screening JV for $1.85 bn

15 Dec 2016

Actelion says J&J backs off, in talks with another suitor

14 Dec 2016

Bayer, Versant Ventures to form JV for stem cell therapy technology

13 Dec 2016

Lonza in advanced talks to buy US capsule products manufacturer Capsugel

13 Dec 2016

AstraZeneca to cut 700 positions

09 Dec 2016

EpiPen maker Mylan to cut and restructure workforce

08 Dec 2016

Pfizer fined for 2,600% price hike

08 Dec 2016

Abbott seeks to terminate $5.8-bn acquisition of Alere

08 Dec 2016

Abbott Laboratories has filed a plaint to terminate its proposed acquisition of Alere Inc due to a "substantial loss" in the value of Alere since the merger agreement was signed